Related Experiment Videos
bcl-2 expression in epidermal keratinocytic diseases
K Nakagawa1, K Yamamura, S Maeda
1Department of Dermatology, Kobe University School of Medicine, Japan.
Cancer
|September 15, 1994
Summary
Bcl-2 protein expression is linked to keratinocytic (KC) skin tumors, potentially enhancing cell survival in malignancies like squamous cell carcinoma (SCC). However, bcl-2 is not significantly expressed in inflammatory skin conditions.
Area of Science:
- Oncology
- Dermatology
- Molecular Biology
Background:
- The bcl-2 protein inhibits apoptosis and is overexpressed in various cancers.
- Skin malignancies commonly originate from epidermal keratinocytes (KC).
- Investigating bcl-2 expression in skin disorders is crucial for understanding tumor development.
Purpose of the Study:
- To analyze bcl-2 protein expression in benign and malignant keratinocytic (KC) skin tumors.
- To investigate the role of bcl-2 in the development of skin tumors and inflammatory skin disorders.
Main Methods:
- Immunohistochemical analysis of bcl-2 protein expression.
- Utilized 72 frozen tissues from various KC proliferations, tumors, and normal skin samples.
- Included chronic dermatitis (CD), psoriasis vulgaris (PV), seborrheic keratosis (SK), actinic keratosis (AK), Bowen's disease (BD), basal cell carcinoma (BCC), and squamous cell carcinoma (SCC).
Main Results:
- Low bcl-2 expression was observed in normal KC, CD, PV, and SK.
- Significant bcl-2 expression was found in Bowen's disease (73%), actinic keratosis (25%), basal cell carcinoma (67%), and squamous cell carcinoma (100%).
- bcl-2 expression was localized to tumors (BCC, BD, SCC), sparing surrounding normal KC.
Conclusions:
- bcl-2 protein expression in KC tumors may correlate with tumorigenic proliferation via enhanced cell survival.
- bcl-2 expression is not associated with inflammatory keratinocyte proliferation.
- The study highlights bcl-2's potential role in the pathogenesis of malignant skin tumors.